Pure Global

“Bisco” TheraCal PT Dual-Cured Resin-Modified Calcium Silicate Pulpotomy Treatment - Taiwan Registration ca44b31d73ad12e6737bca156bb319fd

Access comprehensive regulatory information for “Bisco” TheraCal PT Dual-Cured Resin-Modified Calcium Silicate Pulpotomy Treatment in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ca44b31d73ad12e6737bca156bb319fd and manufactured by BISCO, INC.. The authorized representative in Taiwan is SHI SEI INTERNATIONAL LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
ca44b31d73ad12e6737bca156bb319fd
Registration Details
Taiwan FDA Registration: ca44b31d73ad12e6737bca156bb319fd
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“Bisco” TheraCal PT Dual-Cured Resin-Modified Calcium Silicate Pulpotomy Treatment
TW: “畢斯寇”雙固化矽酸鈣襯底材
Risk Class 2
MD

Registration Details

ca44b31d73ad12e6737bca156bb319fd

Ministry of Health Medical Device Import No. 035190

DHA05603519001

Company Information

United States

Product Details

Details are as detailed as approved Chinese instructions

F Dentistry

F3250 Calcium hydroxide cavity substrate

Imported from abroad

Dates and Status

Jan 20, 2022

Jan 20, 2027